However, in a study by Blanc-Durand et al., a significantly higher expression of TIM3 (76%) was observed compared to PD-L1 (28%) on ovarian cancer tumor samples of 90 and 173 patients, respectively. This evidence concerns the gene HAVCR2 and ovarian carcinoma.